243 related articles for article (PubMed ID: 15241833)
1. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA
Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer.
Fujwara K; Yoshino K; Enomoto T; Fujita M; Ueda Y; Miyatake T; Kimura T; Muraji M; Fujita H; Kimura T; Hori M
Arch Gynecol Obstet; 2011 Dec; 284(6):1501-7. PubMed ID: 21347681
[TBL] [Abstract][Full Text] [Related]
4. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
Axtell AE; Lee MH; Bristow RE; Dowdy SC; Cliby WA; Raman S; Weaver JP; Gabbay M; Ngo M; Lentz S; Cass I; Li AJ; Karlan BY; Holschneider CH
J Clin Oncol; 2007 Feb; 25(4):384-9. PubMed ID: 17264334
[TBL] [Abstract][Full Text] [Related]
5. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
[TBL] [Abstract][Full Text] [Related]
6. Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer.
Everett EN; Heuser CC; Pastore LM; Anderson WA; Rice LW; Irvin WP; Taylor PT
Am J Obstet Gynecol; 2005 Aug; 193(2):568-74; discussion 574-6. PubMed ID: 16098898
[TBL] [Abstract][Full Text] [Related]
7. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
Lou FL; Shi YF
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
[TBL] [Abstract][Full Text] [Related]
8. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
Nelson BE; Rosenfield AT; Schwartz PE
J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230
[TBL] [Abstract][Full Text] [Related]
9. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Mironov S; Iyer RB; Zhou Q; Iasonos A; Paul H; Hosaka M; Aghajanian CA; Leitao MM; Gardner GJ; Abu-Rustum NR; Sonoda Y; Levine DA; Hricak H; Chi DS
Gynecol Oncol; 2014 Sep; 134(3):455-61. PubMed ID: 25019568
[TBL] [Abstract][Full Text] [Related]
10. Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level.
Obeidat B; Latimer J; Crawford R
Gynecol Obstet Invest; 2004; 57(3):153-6. PubMed ID: 14726621
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for suboptimal cytoreduction at primary surgery for advanced stage ovarian cancer.
Gerestein CG; Eijkemans MJ; Bakker J; Elgersma OE; van der Burg ME; Kooi GS; Burger CW
Anticancer Res; 2011 Nov; 31(11):4043-9. PubMed ID: 22110240
[TBL] [Abstract][Full Text] [Related]
12. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer.
Janco JM; Glaser G; Kim B; McGree ME; Weaver AL; Cliby WA; Dowdy SC; Bakkum-Gamez JN
Gynecol Oncol; 2015 Jul; 138(1):70-7. PubMed ID: 25913130
[TBL] [Abstract][Full Text] [Related]
13. A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer.
Gemer O; Gdalevich M; Ravid M; Piura B; Rabinovich A; Gasper T; Khashper A; Voldarsky M; Linov L; Ben Shachar I; Anteby EY; Lavie O
Eur J Surg Oncol; 2009 Oct; 35(10):1109-12. PubMed ID: 19329270
[TBL] [Abstract][Full Text] [Related]
14. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer.
Arits AH; Stoot JE; Botterweck AA; Roumen FJ; Voogd AC
Int J Gynecol Cancer; 2008; 18(4):621-8. PubMed ID: 17868339
[TBL] [Abstract][Full Text] [Related]
16. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of preoperative abdominopelvic CT for optimal cytoreduction surgery in ovarian carcinoma].
Taïeb S; Bonodeau F; Leblanc é ; Vennin P; Fournier C; Besson P
Bull Cancer; 2000 Mar; 87(3):265-72. PubMed ID: 10779815
[TBL] [Abstract][Full Text] [Related]
18. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
Chi DS; Venkatraman ES; Masson V; Hoskins WJ
Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469
[TBL] [Abstract][Full Text] [Related]
19. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
20. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
Gynecol Oncol; 2008 Feb; 108(2):265-70. PubMed ID: 18055006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
